Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia
© 2016 The Author(s). Background: Malaria remains a significant public health issue in Eastern Indonesia, where multidrug resistant Plasmodium falciparum and Plasmodium vivax are highly prevalent. The objective of this study was to describe treatment-seeking behaviour and household costs prior to a...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/40707 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
id |
th-mahidol.40707 |
---|---|
record_format |
dspace |
spelling |
th-mahidol.407072019-03-14T15:01:36Z Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia Muhammad Karyana Angela Devine Enny Kenangalem Lenny Burdarm Jeanne Rini Poespoprodjo Ram Vemuri Nicholas M. Anstey Emiliana Tjitra Ric N. Price Shunmay Yeung Badan Penelitian Dan Pengembangan Kesehatan, Kementerian Kesehatan Republik Indonesia Mahidol University Nuffield Department of Clinical Medicine Papuan Health and Community Development Foundation Mimika District Health Authority University of Gadjah Mada Charles Darwin University Menzies School of Health Research London School of Hygiene & Tropical Medicine Immunology and Microbiology Medicine © 2016 The Author(s). Background: Malaria remains a significant public health issue in Eastern Indonesia, where multidrug resistant Plasmodium falciparum and Plasmodium vivax are highly prevalent. The objective of this study was to describe treatment-seeking behaviour and household costs prior to a change to a unified treatment policy of dihydroartemisinin-piperaquine in Mimika district, Papua province in 2006. Methods: In 2005 a randomized cross-sectional household survey was conducted to collect data on demographics, socio-economic status (SES), treatment-seeking, case management, and household costs. Information on the cost of illness was also collected from patients exiting health facilities, in order to compare the cost of episodes diagnosed as P. vivax compared with those diagnosed as P. falciparum. Results: 825 households were included in the survey. Of the 764 individuals who sought treatment for fever outside the home in the last month, 46% (349/764) went to a public health facility. Of the 894 reported visits to healthcare providers, 48% (433) resulted in a blood test, of which 78% (337) were reportedly positive. Only 10% (17/177) of individuals who reported testing positive for P. falciparum or mixed infection received the first-line treatment of chloroquine with SP, and 38% (61/159) of those with a diagnosis of P. vivax reportedly received the first-line treatment of chloroquine and primaquine. Overall, public facilities were more likely to prescribe the correct prevailing first-line drug combinations than private providers (OR = 3.77 [95% CI 2.31-6.14], p < 0.001). The mean cost to the household of an episode of P. vivax was similar to the cost of P. falciparum [US$44.50 (SD: 46.23) vs US$48.58 (SD: 64.65)]. Conclusions: Private providers were a popular source of treatment for malaria, but adherence to the national guidelines was low and the economic burden of malaria for both P. falciparum and P. vivax infections was substantial. Engagement with the private sector is needed to ensure that patients have access to affordable good quality, effective diagnostics and anti-malarials for both P. falciparum and P. vivax. 2018-12-11T02:56:32Z 2019-03-14T08:01:36Z 2018-12-11T02:56:32Z 2019-03-14T08:01:36Z 2016-11-08 Article Malaria Journal. Vol.15, No.1 (2016), 1-12 10.1186/s12936-016-1588-8 14752875 2-s2.0-84994310907 https://repository.li.mahidol.ac.th/handle/123456789/40707 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84994310907&origin=inward |
institution |
Mahidol University |
building |
Mahidol University Library |
continent |
Asia |
country |
Thailand Thailand |
content_provider |
Mahidol University Library |
collection |
Mahidol University Institutional Repository |
topic |
Immunology and Microbiology Medicine |
spellingShingle |
Immunology and Microbiology Medicine Muhammad Karyana Angela Devine Enny Kenangalem Lenny Burdarm Jeanne Rini Poespoprodjo Ram Vemuri Nicholas M. Anstey Emiliana Tjitra Ric N. Price Shunmay Yeung Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia |
description |
© 2016 The Author(s). Background: Malaria remains a significant public health issue in Eastern Indonesia, where multidrug resistant Plasmodium falciparum and Plasmodium vivax are highly prevalent. The objective of this study was to describe treatment-seeking behaviour and household costs prior to a change to a unified treatment policy of dihydroartemisinin-piperaquine in Mimika district, Papua province in 2006. Methods: In 2005 a randomized cross-sectional household survey was conducted to collect data on demographics, socio-economic status (SES), treatment-seeking, case management, and household costs. Information on the cost of illness was also collected from patients exiting health facilities, in order to compare the cost of episodes diagnosed as P. vivax compared with those diagnosed as P. falciparum. Results: 825 households were included in the survey. Of the 764 individuals who sought treatment for fever outside the home in the last month, 46% (349/764) went to a public health facility. Of the 894 reported visits to healthcare providers, 48% (433) resulted in a blood test, of which 78% (337) were reportedly positive. Only 10% (17/177) of individuals who reported testing positive for P. falciparum or mixed infection received the first-line treatment of chloroquine with SP, and 38% (61/159) of those with a diagnosis of P. vivax reportedly received the first-line treatment of chloroquine and primaquine. Overall, public facilities were more likely to prescribe the correct prevailing first-line drug combinations than private providers (OR = 3.77 [95% CI 2.31-6.14], p < 0.001). The mean cost to the household of an episode of P. vivax was similar to the cost of P. falciparum [US$44.50 (SD: 46.23) vs US$48.58 (SD: 64.65)]. Conclusions: Private providers were a popular source of treatment for malaria, but adherence to the national guidelines was low and the economic burden of malaria for both P. falciparum and P. vivax infections was substantial. Engagement with the private sector is needed to ensure that patients have access to affordable good quality, effective diagnostics and anti-malarials for both P. falciparum and P. vivax. |
author2 |
Badan Penelitian Dan Pengembangan Kesehatan, Kementerian Kesehatan Republik Indonesia |
author_facet |
Badan Penelitian Dan Pengembangan Kesehatan, Kementerian Kesehatan Republik Indonesia Muhammad Karyana Angela Devine Enny Kenangalem Lenny Burdarm Jeanne Rini Poespoprodjo Ram Vemuri Nicholas M. Anstey Emiliana Tjitra Ric N. Price Shunmay Yeung |
format |
Article |
author |
Muhammad Karyana Angela Devine Enny Kenangalem Lenny Burdarm Jeanne Rini Poespoprodjo Ram Vemuri Nicholas M. Anstey Emiliana Tjitra Ric N. Price Shunmay Yeung |
author_sort |
Muhammad Karyana |
title |
Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia |
title_short |
Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia |
title_full |
Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia |
title_fullStr |
Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia |
title_full_unstemmed |
Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia |
title_sort |
treatment-seeking behaviour and associated costs for malaria in papua, indonesia |
publishDate |
2018 |
url |
https://repository.li.mahidol.ac.th/handle/123456789/40707 |
_version_ |
1763487494137970688 |